These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17889431)

  • 1. Multiple variants of the RON receptor tyrosine kinase: biochemical properties, tumorigenic activities, and potential drug targets.
    Lu Y; Yao HP; Wang MH
    Cancer Lett; 2007 Nov; 257(2):157-64. PubMed ID: 17889431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blocking tumorigenic activities of colorectal cancer cells by a splicing RON receptor variant defective in the tyrosine kinase domain.
    Wang MH; Lao WF; Wang D; Luo YL; Yao HP
    Cancer Biol Ther; 2007 Jul; 6(7):1121-9. PubMed ID: 17611409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenesis of RON receptor tyrosine kinase: a molecular target for malignant epithelial cancers.
    Wang MH; Yao HP; Zhou YQ
    Acta Pharmacol Sin; 2006 Jun; 27(6):641-50. PubMed ID: 16723080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel splicing variants of recepteur d'origine nantais (RON) tyrosine kinase involving exons 15-19 in lung cancer.
    Krishnaswamy S; Mohammed AK; Amer OE; Tripathi G; Alokail MS; Al-Daghri NM
    Lung Cancer; 2016 Feb; 92():41-6. PubMed ID: 26775595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel recepteur d'origine nantais/c-met small-molecule kinase inhibitor with antitumor activity in vivo.
    Zhang Y; Kaplan-Lefko PJ; Rex K; Yang Y; Moriguchi J; Osgood T; Mattson B; Coxon A; Reese M; Kim TS; Lin J; Chen A; Burgess TL; Dussault I
    Cancer Res; 2008 Aug; 68(16):6680-7. PubMed ID: 18701492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of the Sema-PSI extracellular domain of human RON receptor tyrosine kinase.
    Chao KL; Tsai IW; Chen C; Herzberg O
    PLoS One; 2012; 7(7):e41912. PubMed ID: 22848655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative genomic analyses of recepteur d'origine nantais and its prognostic value in cancer.
    Yu H; Yuan J; Xiao C; Qin Y
    Int J Mol Med; 2013 May; 31(5):1248-54. PubMed ID: 23483216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion or insertion in the first immunoglobulin-plexin-transcription (IPT) domain differentially regulates expression and tumorigenic activities of RON receptor Tyrosine Kinase.
    Ma Q; Zhang K; Guin S; Zhou YQ; Wang MH
    Mol Cancer; 2010 Nov; 9():307. PubMed ID: 21114864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA-mediated gene silencing of the RON receptor tyrosine kinase alters oncogenic phenotypes of human colorectal carcinoma cells.
    Xu XM; Wang D; Shen Q; Chen YQ; Wang MH
    Oncogene; 2004 Nov; 23(52):8464-74. PubMed ID: 15378025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic and invasive potentials of human macrophage-stimulating protein receptor, the RON receptor tyrosine kinase.
    Wang MH; Wang D; Chen YQ
    Carcinogenesis; 2003 Aug; 24(8):1291-300. PubMed ID: 12807733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel RON splice variant lacking exon 2 activates the PI3K/AKT pathway via PTEN phosphorylation in colorectal carcinoma cells.
    Ling Y; Kuang Y; Chen LL; Lao WF; Zhu YR; Wang LQ; Wang D
    Oncotarget; 2017 Jun; 8(24):39101-39116. PubMed ID: 28388571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of the RON receptor tyrosine kinase in primary human colorectal adenocarcinomas: generation of different splicing RON variants and their oncogenic potential.
    Zhou YQ; He C; Chen YQ; Wang D; Wang MH
    Oncogene; 2003 Jan; 22(2):186-97. PubMed ID: 12527888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in a defined extracellular region of the RON receptor tyrosine kinase promote RON-mediated motile and invasive phenotypes in epithelial cells.
    Zhang K; Zhou YQ; Yao HP; Wang MH
    Int J Oncol; 2010 Jan; 36(1):255-64. PubMed ID: 19956854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RON and RONΔ160 promote gastric cancer cell proliferation, migration, and adaption to hypoxia via interaction with β-catenin.
    Zhou D; Huang L; Zhou Y; Wei T; Yang L; Li C
    Aging (Albany NY); 2019 May; 11(9):2735-2748. PubMed ID: 31085796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RON alternative splicing regulation in primary ovarian cancer.
    Mayer S; Hirschfeld M; Jaeger M; Pies S; Iborra S; Erbes T; Stickeler E
    Oncol Rep; 2015 Jul; 34(1):423-30. PubMed ID: 25997828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the splice variants of Recepteur d'Origine nantais (RON) in lung cancer cell lines.
    Krishnaswamy S; Bukhari I; Mohammed AK; Amer OE; Tripathi G; Alokail MS; Al-Daghri NM
    Gene; 2018 Dec; 679():335-340. PubMed ID: 30223007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splice variants of the extracellular region of RON receptor tyrosine kinase in lung cancer cell lines identified by PCR and sequencing.
    Krishnaswamy S; Mohammed AK; Tripathi G; Alokail MS; Al-Daghri NM
    BMC Cancer; 2017 Nov; 17(1):738. PubMed ID: 29121914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel variant of the RON receptor tyrosine kinase derived from colorectal carcinoma cells which lacks tyrosine phosphorylation but induces cell migration.
    Wang D; Lao WF; Kuang YY; Geng SM; Mo LJ; He C
    Exp Cell Res; 2012 Dec; 318(20):2548-58. PubMed ID: 22975341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting isoforms of RON kinase (MST1R) drives antitumor efficacy.
    Kim J; Koh DI; Lee M; Park YS; Hong SW; Shin JS; Lee MS; Kim MH; Lee JH; Jeong J; Bae S; Hong JK; Jeong HR; Ryu YS; Kim SM; Choi M; Kim H; Ryu H; Hur SC; Park J; Hur DY; Jin DH
    Cell Death Differ; 2023 Dec; 30(12):2491-2507. PubMed ID: 37926711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RON receptor tyrosine kinase in human gliomas: expression, function, and identification of a novel soluble splice variant.
    Eckerich C; Schulte A; Martens T; Zapf S; Westphal M; Lamszus K
    J Neurochem; 2009 May; 109(4):969-80. PubMed ID: 19519771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.